People with schizophrenia have higher levels of antibodies to some Epstein-Barr virus (EBV) proteins (indicating an aberrant response to EBV infection) compared to those without schizophrenia, according to a study in Schizophrenia Bulletin.
Read more via Oxford Academic – Schizophrenia Bulletin.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
